Injectable codeine is obtainable for subcutaneous or intramuscular injection only; intravenous injection is contraindicated, as this can lead to nonimmune mast-cell degranulation and resulting anaphylactoid response. Codeine suppositories are promoted in some nations. In Eire, new rules came into effect on 1 August 2010[90] regarding codeine, as a consequence of https://codeingil.com/